Lanzone A - Search Results

1

Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.

Romualdi D, De Marinis L, Campagna G, Proto C, Lanzone A, Guido M. Romualdi D, et al. Among authors: lanzone a. Clin Endocrinol (Oxf). 2008 Oct;69(4):562-7. doi: 10.1111/j.1365-2265.2008.03204.x. Epub 2008 Jan 31. Clin Endocrinol (Oxf). 2008. PMID: 18248643 Clinical Trial.

2

Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion.

Lanzone A, Fulghesu AM, Guido M, Fortini A, Caruso A, Mancuso S. Lanzone A, et al. Fertil Steril. 1992 Aug;58(2):296-301. doi: 10.1016/s0015-0282(16)55220-0. Fertil Steril. 1992. PMID: 1321739 Free article.

3

Assessment of the adrenal-ovarian contribution by short-term dexamethasone and ACTH tests in hyperandrogenized patients.

Fulghesu AM, Lanzone A, Apa R, Fortini A, Caruso A, Mancuso S. Fulghesu AM, et al. Among authors: lanzone a. Gynecol Endocrinol. 1991 Mar;5(1):37-48. doi: 10.3109/09513599109049940. Gynecol Endocrinol. 1991. PMID: 1654730 Free article.

4

Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease.

Lanzone A, Fulghesu AM, Fortini A, Cutillo G, Cucinelli F, Di Simone N, Caruso A, Mancuso S. Lanzone A, et al. Hum Reprod. 1991 Sep;6(8):1043-9. doi: 10.1093/oxfordjournals.humrep.a137482. Hum Reprod. 1991. PMID: 1666896

5

Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist.

Lanzone A, Fulghesu AM, Andreani CL, Apa R, Fortini A, Caruso A, Mancuso S. Lanzone A, et al. Hum Reprod. 1990 Feb;5(2):143-9. doi: 10.1093/oxfordjournals.humrep.a137058. Hum Reprod. 1990. PMID: 2108986

6

Growth hormone and somatomedin-C secretion in patients with polycystic ovarian disease. Their relationships with hyperinsulinism and hyperandrogenism.

Lanzone A, Fulghesu AM, Pappalardo S, Proto C, Le Donne M, Andreani CL, Muscatello R, Caruso A, Mancuso S. Lanzone A, et al. Gynecol Obstet Invest. 1990;29(2):149-53. doi: 10.1159/000293322. Gynecol Obstet Invest. 1990. PMID: 2110544

7

Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly purified follicle-stimulating hormone in patients with polycystic ovarian disease.

Lanzone A, Fulghesu AM, Spina MA, Apa R, Menini E, Caruso A, Mancuso S. Lanzone A, et al. J Clin Endocrinol Metab. 1987 Dec;65(6):1253-8. doi: 10.1210/jcem-65-6-1253. J Clin Endocrinol Metab. 1987. PMID: 3119655

8

Polycystic ovary disease. A risk factor for gestational diabetes?

Lanzone A, Caruso A, Di Simone N, De Carolis S, Fulghesu AM, Mancuso S. Lanzone A, et al. J Reprod Med. 1995 Apr;40(4):312-6. J Reprod Med. 1995. PMID: 7623362

9

Effectiveness of a somatostatin analogue in lowering luteinizing hormone and insulin-stimulated secretion in hyperinsulinemic women with polycystic ovary disease.

Fulghesu AM, Lanzone A, Andreani CL, Pierro E, Caruso A, Mancuso S. Fulghesu AM, et al. Among authors: lanzone a. Fertil Steril. 1995 Oct;64(4):703-8. doi: 10.1016/s0015-0282(16)57842-x. Fertil Steril. 1995. PMID: 7672138 Free article. Clinical Trial.

10

Differential androgen response to adrenocorticotrophin hormone stimulation and effect of opioid antagonist on insulin secretion in polycystic ovarian syndrome.

Lanzone A, Fulghesu AM, Guido M, Ciampelli M, Caruso A, Mancuso S. Lanzone A, et al. Hum Reprod. 1994 Dec;9(12):2242-6. doi: 10.1093/oxfordjournals.humrep.a138430. Hum Reprod. 1994. PMID: 7714138

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

431 results

Search Page

Filters